{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:08Z","timestamp":1792184648592,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.janxdis.2007.03.001","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T06:02:54Z","timestamp":1173765774000},"page":"310-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder"],"prefix":"10.1016","volume":"22","author":[{"given":"Sarah W.","family":"Book","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.janxdis.2007.03.001_bib1","unstructured":"American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed., text revision). Washington, DC."},{"key":"10.1016\/j.janxdis.2007.03.001_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0005-7967(01)00060-2","article-title":"The Liebowitz Social Anxiety Scale as a self-report instrument: A preliminary psychometric analysis","volume":"40","author":"Baker","year":"2002","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.janxdis.2007.03.001_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.175.2.120","article-title":"Paroxetine in social phobia\/social anxiety disorder: Randomized, double-blind, placebo-controlled study","volume":"175","author":"Baldwin","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib4","series-title":"BDI-II: Beck depression inventory. Manual","author":"Beck","year":"1996"},{"key":"10.1016\/j.janxdis.2007.03.001_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15288\/jsa.1991.52.55","article-title":"Changes in anxiety among abstinent male alcoholics","volume":"52","author":"Brown","year":"1991","journal-title":"Journal of Studies on Alcohol"},{"key":"10.1016\/j.janxdis.2007.03.001_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0376-8716(02)00220-X","article-title":"Alcohol use disorders comorbid with anxiety, depression and drug use disorders\u2014Findings from the Australian National Survey of Mental Health and Well Being","volume":"68","author":"Burns","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.janxdis.2007.03.001_bib7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00127-003-0720-6","article-title":"Considering comorbidity in social phobia","volume":"38","author":"Chartier","year":"2003","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1016\/j.janxdis.2007.03.001_bib8","doi-asserted-by":"crossref","unstructured":"Connor, K. M., Davidson, J. R., Sutherland, S., & Weisler, R. (1999). Social phobia: issues in assessment and management. Epilepsia 40, S60\u2013S65, S73\u2013S74.","DOI":"10.1111\/j.1528-1157.1999.tb00935.x"},{"key":"10.1016\/j.janxdis.2007.03.001_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.176.4.379","article-title":"Psychometric properties of the Social Phobia Inventory","volume":"176","author":"Connor","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00870315","article-title":"Riboflavin as a tracer of medication compliance","volume":"8","author":"Dubbert","year":"1985","journal-title":"Journal of Behavioral Medicine"},{"key":"10.1016\/j.janxdis.2007.03.001_bib11","series-title":"Structured clinical interview for DSM-IV-TR axis I disorders","author":"First","year":"2001"},{"key":"10.1016\/j.janxdis.2007.03.001_bib12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4088\/JCP.v66n1102","article-title":"The epidemiology of social anxiety disorder in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"66","author":"Grant","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib13","series-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.janxdis.2007.03.001_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S0033291798007879","article-title":"Psychometric properties of the Liebowitz Social Anxiety Scale","volume":"29","author":"Heimberg","year":"1999","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.janxdis.2007.03.001_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0962-1849(05)80050-2","article-title":"An overview of the current status of social phobia","volume":"4","author":"Herbert","year":"1995","journal-title":"Applied and Preventive Psychology"},{"key":"10.1016\/j.janxdis.2007.03.001_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1176\/ajp.155.5.613","article-title":"Social phobia subtypes in the National Comorbidity Survey","volume":"155","author":"Kessler","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0272-7358(99)00027-6","article-title":"The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings","volume":"20","author":"Kushner","year":"2000","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.janxdis.2007.03.001_bib19","first-page":"33","article-title":"Comorbidity in social anxiety disorder: Impact on disease burden and management","volume":"59","author":"Lecrubier","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Modern Problems of Pharmacopsychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archpsyc.62.2.190","article-title":"Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder","volume":"62","author":"Liebowitz","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1996.01830020077009","article-title":"Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey","volume":"53","author":"Magee","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archpsyc.1995.03950150062011","article-title":"Generalized social phobia: Reliability and validity","volume":"52","author":"Mannuzza","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02190407","article-title":"Comorbidity and social phobia: Evidence from clinical, epidemiologic, and genetic studies","volume":"244","author":"Merikangas","year":"1995","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.janxdis.2007.03.001_bib25","series-title":"Rockville","article-title":"Motivational enhancement therapy manual","author":"Miller","year":"1995"},{"key":"10.1016\/j.janxdis.2007.03.001_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euroneuro.2004.06.001","article-title":"ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder","volume":"14","author":"Montgomery","year":"2004","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.janxdis.2007.03.001_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cpr.2005.05.004","article-title":"The relationship between social anxiety disorder and alcohol use disorders: A critical review","volume":"25","author":"Morris","year":"2005","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.janxdis.2007.03.001_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jclp.10124","article-title":"A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale","volume":"59","author":"Oakman","year":"2003","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.janxdis.2007.03.001_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/da.1077","article-title":"Paroxetine for social anxiety and alcohol use in dual-diagnosed patients","volume":"14","author":"Randall","year":"2001","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.janxdis.2007.03.001_bib30","first-page":"380","article-title":"Treatment of social phobia and comorbid disorders","volume":"56","author":"Rosenbaum","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2007.03.001_bib31","series-title":"Alcohol dependence scale: Users guide","author":"Skinner","year":"1984"},{"key":"10.1016\/j.janxdis.2007.03.001_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.280.8.708","article-title":"Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial","volume":"280","author":"Stein","year":"1998","journal-title":"The Journal of American Medical Association"},{"key":"10.1016\/j.janxdis.2007.03.001_bib33","unstructured":"Stein, D. J., Ipser, J. C., & Van Balkom, A. J. (2006). Pharmacotherapy for social anxiety disorder. Cochrane Database of Systematic Reviews (Article # CD001206), Issue 3."},{"key":"10.1016\/j.janxdis.2007.03.001_bib34","first-page":"70","article-title":"Ensuring balanced distribution of prognostic factors in treatment outcome research","volume":"12","author":"Stout","year":"1994","journal-title":"Journal of Studies on Alcohol"},{"key":"10.1016\/j.janxdis.2007.03.001_bib35","series-title":"Importance of assessing drinking to cope in individuals with social anxiety disorder","author":"Thomas","year":"2001"},{"key":"10.1016\/j.janxdis.2007.03.001_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-0327(91)90055-W","article-title":"Relationship of social phobia with other psychiatric illness","volume":"21","author":"Van Ameringen","year":"1991","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.janxdis.2007.03.001_bib37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/appi.ps.56.8.913","article-title":"Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder","volume":"56","author":"Watkins","year":"2005","journal-title":"Psychiatric Services"},{"issue":"Suppl. 3","key":"10.1016\/j.janxdis.2007.03.001_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004850-199606003-00004","article-title":"The impact of social phobia on quality of life","volume":"11","author":"Wittchen","year":"1996","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.janxdis.2007.03.001_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0193-953X(05)70254-9","article-title":"Epidemiology, patterns of comorbidity, and associated disabilities of social phobia","volume":"24","author":"Wittchen","year":"2001","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1016\/j.janxdis.2007.03.001_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0033291703007414","article-title":"Evaluation of the clinical global impression scale among individuals with social anxiety disorder","volume":"33","author":"Zaider","year":"2003","journal-title":"Psychological Medicine"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618507000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618507000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:49:54Z","timestamp":1760136594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618507000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"alternative-id":["S0887618507000746"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2007.03.001","relation":{},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2007.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}